CAM
GILD icon

Concorde Asset Management’s Gilead Sciences GILD Stock Holding History

Concorde Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236K Sell
1,692
-228
-12% -$31.9K 0.12% 170
2025
Q4 		$236K Sell
1,920
-654
-25% -$79.5K 0.09% 201
2025
Q3 		$283K Buy
+2,574
New +$293K 0.12% 165
2025
Q1 		$268K Sell
2,537
-42
-2% -$4.33K 0.14% 128
2024
Q4 		$238K Buy
2,579
+59
+2% +$5.31K 0.12% 154
2024
Q3 		$211K Buy
+2,520
New +$192K 0.12% 159
2021
Q2 		– Sell
-3,248
Closed -$212K – 207
2021
Q1 		$212K Buy
+3,248
New +$209K 0.12% 195
2016
Q3 		– Sell
-4,708
Closed -$392K – 128
2016
Q2 		$392K Buy
4,708
+1,053
+29% +$93.5K 0.39% 61
2016
Q1 		$338K Buy
3,655
+435
+14% +$39.2K 0.39% 66
2015
Q4 		$325K Buy
+3,220
New +$335K 0.36% 69
2015
Q3 		– Sell
-4,923
Closed -$576K – 100
2015
Q2 		$576K Buy
4,923
+1,072
+28% +$117K 0.73% 35
2015
Q1 		$378K Buy
3,851
+1,428
+59% +$145K 0.43% 61
2014
Q4 		$242K Buy
+2,423
New +$251K 0.3% 76

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Concorde Asset Management's GILD Position: Q1 2026 in Review

Concorde Asset Management reduced its Gilead Sciences (GILD) stake by 12% in Q1 2026, selling an estimated $31.9K and leaving 1,692 shares worth $236K. The position accounts for 0.12% of the portfolio, ranked #170.

Concorde Asset Management first reported a position in GILD in Q4 2014 and has held it in 13 quarters since. The position peaked at $576K in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Concorde Asset Management held 1,692 shares of Gilead Sciences worth $236K as of Q1 2026.
  • Concorde Asset Management sold 228 Gilead Sciences shares in Q1 2026, an estimated $31.9K.
  • Gilead Sciences made up 0.12% of Concorde Asset Management's portfolio in Q1 2026, its #170 holding.
  • Concorde Asset Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 13 quarters since.
  • Concorde Asset Management's Gilead Sciences position peaked at $576K in Q2 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Concorde Asset Management's 13F filing for Q1 2026, filed 1 Jun 2026.